RAIA DROGASIL S.A. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.332 USD | +22.85% |
|
+12.72% | -25.95% |
| 05-08 | Transcript : Raia Drogasil S.A., Q1 2024 Earnings Call, May 08, 2024 | |
| 05-07 | Raia Drogasil S.A. acquired remaining 15% stake in 4Bio Medicamentos S.A. | CI |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
| Sales 2024 * | 39.18B 7.28B 568B | Sales 2025 * | 44.86B 8.33B 650B | Capitalization | 43B 7.99B 623B |
|---|---|---|---|---|---|
| Net income 2024 * | 1.37B 255M 19.89B | Net income 2025 * | 1.78B 332M 25.87B | EV / Sales 2024 * | 1.28 x |
| Net Debt 2024 * | 7.17B 1.33B 104B | Net Debt 2025 * | 7.71B 1.43B 112B | EV / Sales 2025 * | 1.13 x |
| P/E ratio 2024 * |
31
x | P/E ratio 2025 * |
22.9
x | Employees | 57,708 |
| Yield 2024 * |
1.07% | Yield 2025 * |
1.85% | Free-Float | 74.06% |
More Fundamentals
* Assessed data
More news
Latest transcript on Raia Drogasil S.A.
More press releases
| 1 day | +22.85% | ||
| 1 week | +12.72% | ||
| Current month | +6.84% | ||
| 1 month | +6.63% | ||
| 3 months | -8.90% | ||
| 6 months | -3.24% | ||
| Current year | -25.95% |
1 week
4.05
5.33
1 month
4.055.66
Current year
4.057.95
1 year
4.058.25
3 years
3.4031.86
5 years
2.1031.86
10 years
2.1031.86
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 61 | 30/06/13 | |
| Director of Finance/CFO | 61 | 28/04/13 | |
| Investor Relations Contact | 53 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 63 | 23/11/11 | |
| Director/Board Member | 72 | 28/04/13 | |
| Director/Board Member | 46 | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/06/24 | 5.332 | +22.85% | 204 |
| 06/06/24 | 4.34 | -8.25% | 1,416 |
Delayed Quote OTC Markets, June 10, 2024 at 03:21 pm
More quotes
Raia Drogasil S.A. specializes in the distribution of medicines, cosmetics and dermocosmetics, perfumery, personal care and beauty products. Net sales break down by family of products as follows:
- branded pharmaceuticals (42%);
- pharmaceutical additives (25.1%) ;
- OTC products (21.3%);
- generic pharmaceutical products (11.4%).
At the end of 2020, its products were marketed through a network of 2,299 pharmacies under the Drogasil (1,304) and Raia (995) brands in Brazil.
Sector
Drug Retailers
Calendar
05/08/2024
- Q2 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
25.07
BRL
Average target price
30.5
BRL
Spread / Average Target
+21.66%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +22.46% | 1.29B | |
| -14.60% | 338M | |
| -0.71% | 266M | |
| +10.56% | 225M | |
| -17.43% | 80.97M | |
| +28.41% | 63.3M |
- Stock Market
- Equities
- RADL3 Stock
- RADLY Stock
